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Access to healthcare is a fundamental human right that has
been enshrined in international treaties and recognized by govern-
ments around the world.1–3 However, this fundamental right to
health cannot be fulfilled when prescribers fail to comply with
the Standard Treatment Guidelines (STG).
The STG is a list that contains the preferred pharmaceutical and
nonpharmaceutical treatments for common health problems expe-
rienced by people in a specific health system. For each health prob-
lem, the pharmaceutical treatment is mentioned along with the
dosage form, strength, average dose (pediatric and adult), number
of doses per day, and number of days of treatment.4 STG are used at
different points of the therapeutic process. They may be used to
diagnose, decide on treatment and pharmaceutical supply, and
assist with adherence to the prescribed treatment thereby leading
to the desired clinical outcome.4
The utilization of STG is necessary for therapeutically effective
and economically efficient use of medicines.4 When implemented
effectively, an STG offers advantages to all stakeholder: patients
(e.g., it provides more consistency and treatment efficacy), Health-
care providers (e.g., it gives an expert consensus, quality of care
standard, and basis for monitoring), supply managers (e.g., it
makes demand more predictable and allows for prepackaging),
and health policy makers (e.g., it provides focus for therapeuticin-
tegration of special programs and promotes efficient use of funds).4
For health care providers, it actually provides standardized guid-
ance to practitioners; encourages high quality care by directing
practitioners to the most appropriate medicines for specific condi-
tions; encourages the best quality of care since patients are receiv-
ing optimal therapy; utilizes only formulary or essential medicines,
so the health care system needs to provide only the medicines in
the STGs; provides valuable assistance to all practitioners,especially to those with lower level skills like Primary Heath Care
workers; enables providers to concentrate on making the correct
diagnosis because treatment options will be provided for them.4
Presently, STG are in use in parts of the United States of Amer-
ica, Europe, Latin America, Asia, Africa, and the Western Pacific.4 In
Nigeria, the first edition of the national STGs was published in 2008
by the Federal Ministry of Health in collaboration with World
Health Organization and DFID (Department for International
Development).5 However, Kaduna state was the first of thirty-six
Nigerian states to prepare a STG for the purpose of streamlining
clinical practices within its healthcare delivery system.6 Its maiden
edition of STG was published in 2012 in collaboration with PATHS
2 (Partnership for Transforming Health Systems 2) and DFID.
Unlike Kaduna state, Nassarawa state (where our study facility is
located) has no state STG but uses the national STG.
Effective implementation, however, is perhaps the greatest
challenge in introducing STGs.4 One of the factors impeding imple-
mentation of STGs is that they are not always available in wards/
healthcare centres even when nationally produced.7 Other chal-
lenges facing STGs is that of conflict of interes. Several studies have
shown that conflicts of interest do affect the development process
of clinical practice guidelines in several countries especially influ-
ence by pharmaceutical companies.8–10 For example, the study
conducted by Cosgrave et al, revealed that the prevalence of con-
flicts of interest among guideline development panel members
was high. Financial ties to industry were disclosed by all members
(100%) of the guideline development committee with members
reporting a mean 20.5 relationships (range 9–33). Most of the com-
mittee members participated on pharmaceutical companies’
speakers’ bureaus.8
Essential Medicine List is a list of minimum medicines that are
needed for a basic health-care system. The list contains the most
efficacious, safe and cost–effective medicines for priority condi-
tions.11 The List is promoted by the World Health Organization
(WHO) as a means to facilitate equality in access to medicines
across the globe. It has been created to satisfy the priority health
care needs of societies in terms of availability and affordability of
Table 1
Socio-demographic Characteristics of respondents.
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EMLs have influenced the provision of medicines and have resulted
in a higher availability of essential medicines compared to non-
essential medicines particularly in the public sector and in low
and lower middle income countries.13 The findings revealed that
the overall median availability of essential medicines for any pro-
duct type was 61.5% while the availability of non-essential medici-
nes was 27.3%. In the public sector, the median availability of
essential and non-essential medicines was 40.0% and 6.6% respec-
tively for any product type.13 Availability also differ across income
groups: in upper-middle income countries the availability of orig-
inator brands was considerably higher than other income groups
both for essential and non-essential medicines (40% availability
in both groups). Median availability of the two groups of medicines
(essential vs. non-essential) differed significantly in low and lower-
middle income countries for any product type of medicines (Differ-
ence = 25% and 11.3% respectively; p, 0.05).13
One justification for including Hospital Drug Formulary (HDF)
in the study is that, just like EML, it is another document that is
important to both prescribers and patients in a hospital setting.
It is a continuously revised compilation of pharmaceutical dosage
agents with its important information which reflects the current
clinical judgment of the medical staff. The hospital formulary sys-
tem is a method whereby the medical staff of a hospital with the
help of pharmacy and therapeutic committee selects and evaluate
medical agents and their dosage form which are considered to be
most useful in the patient care. It provides information for procur-
ing, prescribing, dispensing and administration of drug under non
proprietary names and instance where drugs have both names.14
Our study facility has a Drug and Therapeutics Committees
(DTC) that was established in 2016. The DTC has five sub-commit-
tees (Policy and Guidelines; Pharmacovigilance and Drug Informa-
tion; Drug Formulary; Drug Utilization Review and Need
Quantification; Publicity) and all the sub-committees have five
members, excluding Drug Formulary which has seven. The DTCs
has been functioning sub optimally, which is a common problem
with DTCs in Nigeria where only half (50%) of the DTCs meet reg-
ularly15 and often times, this is due to lack of local expertise or a
lack of incentives.16
This study was conducted to assess Prescriber’s awareness of
Essential Medicine List, Hospital Drug Formulary and utilization
of STGs in a tertiary healthcare facility in North-Central Nigeria.
It is the first of its kind in the study facility, and a search in all rec-
ognized internet search engines (using the research topics)














Ear Nose & Throat (ENT) 1 1.4
Surgery 1 1.4
Dental Surgery 5 7.1
Accident and Emergency (A&E) 5 7.1
Paediatrics 7 10
Obstetrics & Gynaecology 10 14.3
Internal Medicine 12 17.1
Specialty clinics 13 18.6
Family Medicine (GOPD) 16 22.92. Methods
A cross-sectional descriptive study conducted in a 300 bed ter-
tiary healthcare facility, situated in Keffi town which is approxi-
mately 68 km from Abuja, Nigeria’s federal capital territory. It is
128 km from lafia town which is the state capital of Nasarawa
state. Keffi is located between latitude 850N of the equator and
longitude 780E of the Greenwich meridian and is situated on an
altitude of 850 m above sea level.17 The study population com-
prises 70 Medical Doctors who were prescribers and within the
cadre of Medical Officers, Registrars and consultants in various
clinics of the hospital. A Sample size of 70 was obtained using
the formula n = z2pq/d2. Respondents were selected using simple
random sampling technique in which the staff list served as the
sampling frame. Proportionate allocation technique was used to
select respondents from the 3 different cadres. A structured, pre-
tested self-administered questionnaire was used for data collec-
tion. The questionnaire assessed the socio-demographic profile of
respondents and their Awareness of Essential Medicine List, Hospi-tal Drug Formulary and Prescribing using generic names. Data con-
cerning availability and utilization of STGs were gathered using a
check-list. The variables in the questionnaire were selected based
on rational drug use studies.18–20 The questionnaire was pretested
on 10 randomly selected prescribers in National Hospital, Abuja,
Nigeria, a tertiary health facility with similar characteristics with
the study area and 69.6 km away from study area.
The administered questionnaires were analyzed using SPPS sta-
tistical software (version 20). Ethical clearance for the study was
obtained from the Human Research and Ethics Committee of Fed-
eral Medical Centre, Keffi, Nigeria (Reference number: FMC/KF/
HREC/083/15).3. Results
As shown in Table 1, a total of 70 respondents participated in
the study. Majority (52.9%) of the respondents were in the age
group of 31–40 years and were mostly males (71.4%). Most of the
respondents (52.9%) were in service for 5 or less than 5 years while
34.3% were in service between 6 and 10 years. Only a small propor-
tion of the respondents (8.6%) have served for 11–15 years while
those that served for 16 or greater than 16 years constitute just
4.3%. In terms of cadre, majority of the respondents (50%) were
Medical officers, while 44.3% were registrars and 5.7% were Con-
sultants. In terms of specialty, 22.9% were in Family Medicine;
18.6% were in specialty clinics; 17.% were in Internal Medicine;
14.3% were in Obstetrics and Gynaecology; 10% were in paedi-
atrics; 7.1% were in Accident and Emergency; 7.1% were in dental
Surgery; 1.4% were in Surgery unit and 1.4% were in Ear, Nose &
Throat (ENT) unit.
As shown in Table 2, majority of the respondents (51.4%) were
aware of EML, 35.7% were not aware of it, while 10% were not sure.
Regarding possession of an EML, majority of the respondents
(77.1%) claim to have a copy of it while 15.7% do not have a copy.
Only 2.9% were not sure if they have a copy. As regards HDF, 41.4%
of respondents were aware of it while 31.4% were not aware of it.
Only 5.7% of respondents were not sure of HDF. As for possession of
Table 2
Respondent’s awareness of Essential Medicine List (EML), Hospital Drug Formulary (HDF) and Utilization of Standard Treatment Guidelines.
Yes (%) No (%) Not sure (%) No response (%)
Awareness of EML 36(51.4) 25(35.7) 7(10) 2(2.9)
Possesion of EML 54(77.1) 11(15.7) 2(2.9) 3(4.3)
Awareness of HDF 29(41.4) 22(31.4) 4(5.7) 15(24.1)
Presciption using generic names 56(80) 12(17.1) 2(2.9) 0
Possesion of STG 21(30) 49(70) 0 0
Need a copy of STG 53(78.6) 13(18.6) 1(1.4) 1(1.4)
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(70%) do not. Majority of the respondents (78.6%) claimed they
need a copy of the STG while 18.6% claimed they don’t need it
and only 1.4% were not sure if they need it.4. Discusssion
The study assessed prescriber’s awareness of Essential Medicine
List, Hospital Drug Formulary and Utilization of Standard Treat-
ment Guidelines in Federal medical centre, keffi (a tertiary health-
care facility in Nasarawa state, North-Central Nigeria). In this
section, there is limited comparison of our findings with other
studies because there are no studies on same subject matter (to
the best of our knowledge). A search of the digital electronic data-
base using the 4 free text keywords ‘‘Awareness” ‘‘Essential
medicines List” ‘‘Standard Treatment Guidelines” ‘‘Utilization”
yielded no results in Google search, Google scholar, and African
journals online (AJOL). This unproductive search made the authors
to conclude that this study is the first of its kind.
The health care workforce in the study facility was predomi-
nantly young and this was reflected in their age group where
majority (90%) were aged between 21 and 40 years. It also reflected
in the years of service where majority (52.9%) where less than
6 years in service. This young nature of participants could affect
their awareness of Essential Medicine List, Hospital Drug Formu-
lary and Utilization of Standard Treatment Guidelines.
Among respondents, consultants were few compared to medi-
cal officers and registrars. This is because, as one progresses along
the cadre, the number of consultants, who are mostly older and at
the top of the control chain, becomes relatively few.
The high level of awareness of EML (51.4%) could be due to sev-
eral factors such as its availability in the study facility since 77.1%
of respondents own a copy. This high level of awareness and access
to EML was most likely responsible for the high level (80%) of pre-
scription using generic names. This is a good development and in
line with Nigerian National Drug Policy.21 On the other hand,
awareness of HDF was low (41.4%). This could be due to non-avail-
ability of HDF or low access to it among health workers.
Majority of the respondents (70%) do not have STG. This is a dis-
turbing finding because prescribers cannot utilize STG when they
don’t even have a copy of it. This indirectly implies that only a
low proportion (30%) were utilizing the STG. This low level of uti-
lization and access to STG is similar to findings from another
related study in in Lagos, Nigeria, where only 13% of the doctors
in an army hospital possessed the current National Antimalarial
Treatment Guidelines.22 In a related study in Sri Lanka, less than
40% of medical practitioners were aware of STG.23 Most of respon-
dents (78.6%) in our study claimed they need a copy of the STG.
Based on findings of this study, the authors suggest that the
drug and therapeutics committee of the study facility needs to hold
regular meetings and follow up on prescribing practices and adher-
ence to STGs. Also, since STGs are readily available on the internet,
it is recommended that the hospital DTC should download it and
make it available to prescribers and in the wards. Prescribers
should also be encouraged to download the documents and storethem in their mobile phones for easy and fast access at any time
and any place. There is also need to put in place strategies that will
ensure compliance such as training/update workshops on STG and
constitution of a monitoring and evaluation unit for the DTC
(which is currently missing). Other measures that can improve
compliance include ensuring physician trust in those developing
the guidelines, as this was one of the factors that resulted in a high
adherence rate (over 90%) to the ’Wise List’ in Stockholm County
(Region) in Sweden. This is a list of approx. 200 medicines that
were carefully selected using evidence based principles by a mul-
tidisciplinary expert group.24
Other limitations of the study include Recall and Courtesy bias
which cannot be ruled out in the study. The former has to do with
respondent’s inability to correctly recollect an event due to long
time lag while the latter has to do with respondents telling inter-
viewers what they think they’d like to hear.5. Conclusion
The results indicated high awareness of EML and HDF but a very
low access to STG and its utilization among prescribers in the study
facility. It is recommended that the hospital DTC should download
STGs from the internet and make it available to prescribers and in
wards and put in place strategies that will ensure compliance. This
will benefit patients by improving consistency and treatment effi-
cacy. It will also benefit providers by improving their quality of
care standard and serve as a basis for monitoring. It will also ben-
efit the management of the facility because it will make demand
more predictable and allow for prepackaging.Conflict of interest
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